Teresa Amaral

21PUBLICATIONS
71CO-AUTHORS
Cancer geneticsEnvironmental epidemiologyRadiation therapyPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Nov 14, 2025
Genetic susceptibility in early-onset melanoma: An observational Greek cohort study.

Eftychia Chatziioannou, Katerina Kypreou, Irene Stefanaki

|Nov 06, 2025
Messages for ultraviolet-radiation protection to fair-skinned populations.

Lieve Brochez, Claus Garbe, Teresa Amaral

|Jan 11, 2025
Correction: Peisen et al. Can Delta Radiomics Improve the Prediction of Best Overall Response, Progression-Free Survival, and Overall Survival of Melanoma Patients Treated with Immune Checkpoint Inhibitors? <i>Cancers</i> 2024, <i>16</i>, 2669.

Felix Peisen, Annika Gerken, Alessa Hering

|Aug 10, 2024
Can Delta Radiomics Improve the Prediction of Best Overall Response, Progression-Free Survival, and Overall Survival of Melanoma Patients Treated with Immune Checkpoint Inhibitors?

Felix Peisen, Annika Gerken, Alessa Hering

|May 20, 2024
Exploring 'decision regret' in adjuvant-treated melanoma patients: Results from a cross-sectional survey on 200 participants.

T Grünke, S Reiter, S Meyer

|Oct 28, 2023
Can Whole-Body Baseline CT Radiomics Add Information to the Prediction of Best Response, Progression-Free Survival, and Overall Survival of Stage IV Melanoma Patients Receiving First-Line Targeted Therapy: A Retrospective Register Study.

Felix Peisen, Annika Gerken, Alessa Hering

Pageof 4

Frequent Collaborators

6 joint publications

Claus Garbe

6 joint publications

Ulrike Leiter

4 joint publications

Thomas Kurt Eigentler

4 joint publications

Konstantin Nikolaou